J. W. Marsh, I. Dvorchik, M. Subotin, V. Balan, J. Rakela, E. P. Popechitelev, V. Subbotin, A. Casavilla, B. I. Carr, J. J. Fung and S. Iwatsuki, “The Prediction of Risk of Recurrence and Time to Recurrence of Hepatocellular Carcinoma after Orthotopic Liver Transplantation: A Pilot Study,” Hepatology, Vol. 26, No. 2, 1997, pp. 444-450. doi:10.1002/hep.510260227

has been cited by the following article:

• TITLE: Multi-Detector-Row CT Diagnosis of Adrenal Incidentaloma in Patients with Hepatocellular Carcinoma

  AUTHORS: Taisuke Harada, Tamotsu Kamishima, Satoshi Terae, Yuya Onodera, Hiroki Shirato

  KEYWORDS: CT; Adrenal Incidentaloma; Hepatocellular Carcinoma; Lipid-Poor Adrenal Adenomas; Metastatic Adrenal Tumors

  JOURNAL NAME: Advances in Computed Tomography, Vol.2 No.1, March 28, 2013

  ABSTRACT: We investigate the diagnostic reliability of differentiating between lipid-poor adrenal adenomas and metastatic adrenal tumors originating from hepatocellular carcinoma (HCC) using a routine dynamic CT protocol for liver imaging. Eighteen metastatic adrenal tumors originating from HCC and 13 lipid-poor adrenal adenomas were identified. Dynamic CT data were analyzed for CT attenuation of adrenal lesions before and after contrast administration. When a cutoff of 36 HU was set for adrenal lesions at pre-contrast attenuation, the sensitivity and specificity for the diagnosis of metastatic lesions were 94.4%and 92.3%, respectively. Attenuation criteria on pre-contrast CT may help optimize the differentiation between these lesions.